AstraZeneca 2Q profit up 22 pct

By JANE WARDELL - AP Business Writer - Associated Press Thursday, July 29, 2024

newsvine diigo google
slashdot
Share
Loading...

AstraZeneca PLC doubled its share buyback program on Thursday after posting strong second quarter results and revealing that a key new drug — its blood thinner Brilinta — has been given a thumbs up by an advisory committee of the U.S. Food and Drug Administration.

The Anglo-Swedish drugmaker also raised its full-year earnings forecast after reporting a net profit of $2.1 billion for the three months to June 30, compared with a $1.72 billion profit in the same period a year ago.

Revenue rose 2.8 percent to $8.18 billion, from $7.96 billion, as strong sales in emerging markets outweighed declining revenue in the United States, where it faces tough generic competition for its products.

That competition is expected to intensify in the second half of the year as key products come off patent and AstraZeneca loses unexpected factors that boosted its 2009 earnings, like the swine flu outbreak.

But a lack so far of generic copies of its ulcer drug Nexium in Europe and a court win last month upholding its U.S. patent on cholesterol drug Crestor has given the company some renewed confidence.

It lifted its earnings per share forecast for the fourth time, to $6.35-$6.65 per share from the $6.05-$6.35 per share it predicted when it announced first quarter earnings in April. It also doubled its share buyback program to $2 billion.

"Our second quarter performance reflects continued strong growth in our emerging markets and good performance for key brands Crestor, Seroquel and Symbicort," Chief Executive Officer David Brennan said.

The company reported a 23 percent increase in sales of Crestor to $1.43 billion; a 20 percent gain for the asthma drug Symbicort to $664 million, and an 8 percent rise for the anti-psychotic drug Seroquel to $1.35 billion.

The company's shares were bid up after the financial update, rising 4.2 percent to 3,337 pence in morning trade on the London Stock Exchange.

Panmure Gordon analysts said the earnings were better than anticipated, and even though a tougher second half is expected, "we remain conviction buyers as we expect significant upgrades to consensus."

However, Collins Stewart analyst Emmanual Papadakis warned that the second quarter represented the last pre-key patent expiry set of results, with Brilinta's recommendation the last of the significant expected positive newsflow.

"We would advise taking profits post a very strong run that is likely to start reversing H2 10," Papadakis said in a note.

FDA advisory committee members voted 7 to 1 to recommend the approval of Brilinta in patients with acute coronary syndrome, or blocked arteries. The FDA usually follows the advice of its advisory committee, which made the finding despite revelations earlier this week that study results in the U.S. did not match the positive reports from abroad.

An international, 18,000-patient study conducted by AstraZeneca showed that patients taking Brilinta versus Plavix were less likely to experience various heart-related problems, including heart attack and stroke. But U.S. patients studied were more likely to report heart problems while taking Brilinta.

AstraZeneca needs Brilinta to help fill a gap in its drugs pipeline as revenue from both Seroquel and Nexium — which had flat sales of $1.26 billion in the quarter — are hurt by generic competition.

The blood thinner market is currently dominated by Sanofi-Aventis SA and Bristol-Myers Squibb Co.'s blockbuster drug Plavix. With global sales of $9.1 billion in 2009, Plavix was the world's second-best selling drug behind Pfizer Inc.'s cholesterol drug Lipitor.

Eli Lilly & Co. launched its own drug, Effient, last summer, but it has faced an uphill climb with sales of $22.9 million in the last quarter.

Join the Discussion
Rate Article: Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Research Exchange

New Frontiers: The Changing World of Biospecimen Collection and Management

12 hours ago

The growth of biomarker research and personalized medicine requires more unified and large-scale software systems to track biological materials.

Optical Imaging in Stem Cell Research

Jun 1

Developing sensitive, non-invasive technologies to monitor engraftment in vivo is essential to accelerate the clinical implementation of cell therapies.

Standing Up in a Court of Law

Jun 1

Private forensic testing laboratory ensures data integrity with advanced calibration systems.

Simultaneous Measurement of Multiple Signaling Pathways in Human Leukemias Using Flow Cytometry

May 24

Next generation assays will need to be robust and standardized in order to make the transition from a research procedure to a routine clinical assay. Flow cytometry provides a unique and sensitive method to accomplish these requirements.

Step up to the MIQE

Mar 30

Over the years, polymerase chain reaction (PCR) has evolved into a readily automated, high throughput quantitative technology. Real-time quantitative PCR (qPCR) has become the industry standard for the detection and quantification of nucleic acids for multiple application, including quantification of RNA levels. But a lack of consensus among researchers on how to best perform and interpret qPCR experiments presents a major hurdle for advancement of the technology. This problem is exacerbated by insufficient experimental detail in published work, which impedes the ability of others to accurately evaluate or replicate reported results.

Fast Optimization of a Multiplex Influenza Identification Panel Using a Thermal Gradient

Mar 30

The year 2009 was marked by the emergence of a novel influenza A (H1N1) virus that infects humans. There is a need to identify the different strains of influenza virus for purposes of monitoring the H1N1 strain pandemic and for other epidemiological and scientific purposes.

Advantages of Monolithic Laser Combiner Technology in Confocal Microscopy Systems

Jan 6

Fluorescence microscopy techniques require a reliable light source at the desired wavelength or wavelengths, with minimal downtime for maintenance and alignment. Lasers are a popular light source, although the alignment and upkeep of laser combiners is a time-consuming prospect for many users.

Size-Exclusion Chromatography for Purification of Biomolecules

Dec 2 2009

Size-exclusion chromatography (SEC) is a popular method to separate biomolecules based on their size. Primarily, it is applied to the separation of biopolymers such as proteins and nucleic acids, i.e. water-soluble polymers.

Using the Tecan Genesis Workstation to Automate a Cytometric Bead Array (CBA) Immunoassay

Mar 11

The poster describe the process involved in automating a Cytometric Bead Array (CBA) immunoassay developed to measure relative concentrations of serum antibodies against Tetanus (TT), Sperm Whale Myoglobin (SWM) and Keyhole Limpet Hemocyanin (KLH) in KLH-immunized volunteers.

Ensuring Quality in Assays Performed with Automated Liquid Handlers

Feb 2

The focus of this presentation is to highlight the need of ensuring quality in important assays performed with automated liquid handlers. Nearly all assays performed within a laboratory are volume-dependent. In turn, all concentrations of biological and chemical components in these assays, as well as the associated dilution protocols, are volume-dependent. Because analyte concentration is volume-dependent, an assay’s results might be falsely interpreted if liquid handler variability and inaccuracies are unknown or if the system(s) go unchecked for a long period.

Inkjet System for Protein Crystallography

Feb 1

X-ray crystallography is used routinely by scientists to obtain the three dimensional structure of a biological molecule of interest.Such information can be used to determine how a pharmaceutical interacts with a protein target and what changes might improve functionality. However, the crystallization of macromolecules still remains a serious hindrance in structural determination despite impressive advances in screening methods and technologies.

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Attention Deficit & Hyperactivity in a Drosophila Memory Mutant

Nov 9 2009

Action selection is modulated by external stimuli either directly or via memory retrieval. In a constantly changing environment, animals have evolved attention-like processes to effectively filter the incoming sensory stream. These attention-like processes, in turn, are modulated by memory. The neurobiological nature of how attention, action selection and memory are inter-connected is unknown. We describe here new phenotypes of the memory mutant radish in the fruit fly Drosophila.

Bile acids regulate hepatic gluconeogenic genes and farnesoid X receptor via G(alpha)i-protein-coupled receptors and the AKT pathway.

2 hours ago

Bile acids are important regulatory molecules that can activate specific nuclear receptors and cell signaling pathways in the liver and gastrointestinal tract. In the current study, the chronic bile fistula (CBF) rat model and primary rat hepatocytes (PRH) were used to study...

Purification of the CaaX-modified, dynamin-related large GTPase hGBP1 by coexpression with farnesyltransferase.

3 hours ago

Over a hundred proteins in eukaryotic cells carry a C-terminal CaaX box sequence, which targets them for posttranslational isoprenylation of the cysteine residue. This modification, catalyzed by either farnesyl or geranylgeranyl transferase, converts them into peripheral...

Genome Sequence of a Cellulose-Producing Bacterium, Gluconacetobacter hansenii ATCC 23769.

5 hours ago

The Gram-negative bacterium Gluconacetobacter hansenii is considered a model organism for studying cellulose synthesis. We have determined the genome sequence of strain ATCC 23769.

Novel Antileukemic Compound Ingenol 3-Angelate Inhibits T Cell Apoptosis by Activating Protein Kinase C{theta}.

6 hours ago

Members of the protein kinase C (PKC) family of serine-threonine kinases are important regulators of immune cell survival. Ingenol 3-angelate (PEP005) activates a broad range of PKC isoforms and induces apoptosis in acute myeloid leukemia cells by activating the PKC isoform...

Prokariotic Cell Collection in Denmark

Nov 6 2009

I would like to know about a prokariotic cell collection in Denmark. Is there a cell bank in this country? I need a Lactobacillus strain for a fermentation assay and this information about the bank is very helpful for me.

Request for Entries

Oct 16 2009

Ask the Experts is your chance to get the answers to questions on applications, materials, methods, processes, and technologies. Email you question to bst_web@advantagemedia.com, and the editors of Bioscience Technology will find an appropriate expert to answer it. Watch this space in the future to see the questions your colleagues are posting.

STAY INFORMED: SUBSCRIBE TO

Magazine and E-mail Newsletters

Loading...
E-mail:   

MULTIMEDIA

Video:

Viewing SureFocus Slides

Jun 11

A demonstration of SureFocus Microscope Slides in the review of AFB Smears. SureFocus Slides are a patent-pending breakthrough in tuberculosis detection, as their fluorescent staining circle remains visible during review, Fluorescence Microscopy.

Podcasts:

Allen Institute for Brain Research

Allen Institute for Brain Research

Oct 14 2009

Discussed in this interview are both the mouse brain project and the human cortex project with an emphasis on the importance of these projects to neuroscience research.

Information: